Evidence map›Paper›PMID 26739651›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2016

Adropin acts in brain to inhibit water drinking: potential interaction with the orphan G protein-coupled receptor, GPR19.

Lauren M Stein, Gina L C Yosten, Willis K Samson

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Targeting GCell reports. Medicine · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Adropin: A New Regulator of Testicular Function-What Do We Know So Far?International journal of molecular sciences · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Hepatic interoception in health and disease.Autonomic neuroscience : basic & clinical · 2024
    Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lauren M SteinDepartment of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, Missouri.
Gina L C YostenDepartment of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, Missouri.
Willis K SamsonDepartment of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, Missouri samsonwk@slu.edu.
Saint Louis University · US

Funding

Pharmacological Sciences Training GrantT32GM008306 · NIGMS · SAINT LOUIS UNIVERSITY · PI EGAN, TERRANCE M, WALKER, JOHN K. · 1990 to 2020
$3.6M
Angiotensin Receptor Regulation By Upstream Short Open Reading FramesR01HL121456 · NHLBI · GEORGETOWN UNIVERSITY · PI SAMSON, WILLIS K., SANDBERG, KATHRYN L · 2014 to 2017
$3.1M
NHLBI NIH HHS 1 R01 HL-121456NIGMS NIH HHS T32 GM008306NIGMS NIH HHS T32-GM008306
6 · The paper itself

Abstract

Adropin, a recently described peptide hormone produced in the brain and liver, has been reported to have physiologically relevant actions on glucose homeostasis and lipogenesis, and to exert significant effect on endothelial function. We describe a central nervous system action of adropin to inhibit water drinking and identify a potential adropin receptor, the orphan G protein-coupled receptor, GPR19. Reduction in GPR19 mRNA levels in medial basal hypothalamus of male rats resulted in the loss of the inhibitory effect of adropin on water deprivation-induced thirst. The identification of a novel brain action of adropin and a candidate receptor for the peptide should extend and accelerate the study of the potential therapeutic value of adropin or its mimetics for the treatment of metabolic disorders.

Indexed as

AnimalsArterial PressureBlood ProteinsBrainDose-Response Relationship, DrugDrinking BehaviorEatingHypothalamus, MiddleInjections, IntraventricularMaleNerve Tissue ProteinsPeptidesRatsRats, Sprague-DawleyReceptors, G-Protein-CoupledReceptors, NeurotransmitterBlood ProteinsENHO protein, ratGPR19 protein, ratNerve Tissue ProteinsPeptidesReceptors, G-Protein-CoupledReceptors, NeurotransmitterRNA, MessengeradropinG protein-coupled receptorhypothalamusthirst

Identifiers

PMID26739651
PMCPMC4867374
OpenAlexW2223022678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.